Torben Vedel Stahl Jörgensen

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

Part of Biotage AB, Biotage GB Ltd. is a British company that manufactures and distributes chromatography accessories, consumables, and instruments. The private company is based in Cardiff, UK. Biotage GB was acquired by Argonaut Technologies, Inc. on February 20, 2002 for $17.82 million.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Advanced Instruments, Inc. designs, manufactures and markets laboratory test equipment and related consumables for use in clinical, food and dairy, microbiology, pharmaceutical and biotech markets. The company was founded in 1955 and is headquartered in Norwood, MA.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.